The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...

The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) has initiated the human trial of ARO-ALK7, a novel RNA interference (RNAi) ...

Bio-Path Holdings, Inc. (OTCQB: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (OTCQB: BPTH) for Q1 2025. Bio-Path Holdings, Inc. (OTCQB: BPTH) is a clinical-stage ...

A startup seeking to replace animal testing with a sophisticated high-tech platform has raised $40 million to develop ...

Adding zilebesiran to a thiazide diuretic or calcium channel blocker may lead to further blood pressure reduction in patients with uncontrolled hypertension. Zilebesiran added to hypertension ...

A start-up that launched only 8 months ago has attracted the attention of Biogen, a major developer of neurological drugs.

Results from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that ...